Last reviewed · How we verify
Preloading before TAVI
Preloading before TAVI is a strategy to improve outcomes by reducing the risk of complications during transcatheter aortic valve implantation.
Preloading before TAVI is a strategy to improve outcomes by reducing the risk of complications during transcatheter aortic valve implantation. Used for Preloading before TAVI for reducing complications during the procedure.
At a glance
| Generic name | Preloading before TAVI |
|---|---|
| Also known as | ASS, Plavix |
| Sponsor | Charite University, Berlin, Germany |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
This involves administering a medication before the procedure to stabilize the patient and reduce the risk of bleeding, stroke, or other complications. The exact mechanism of action is not well established, but it is thought to involve anti-inflammatory and anti-thrombotic effects.
Approved indications
- Preloading before TAVI for reducing complications during the procedure
Common side effects
- Bleeding
- Stroke
- Infection
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Preloading before TAVI CI brief — competitive landscape report
- Preloading before TAVI updates RSS · CI watch RSS
- Charite University, Berlin, Germany portfolio CI